<p>Cresco Labs（OTCMKTS:CRLBF - 获取免费报告）于周五发布了季度财报。该公司报告的每股收益（EPS）为（$0.05），低于市场共识预期的（$0.03），差距为（$0.02），据 Zacks 报道。该季度的收入为 1.65 亿美元，而分析师预期为 1.6374 亿美元。Cresco Labs 的股本回报率为负 11.77%，净利润率为负 6.67%。</p>
<h2>Cresco Labs 价格表现</h2>
<p>OTCMKTS:CRLBF 周五开盘价为$1.07。该股票的市值为 3.8085 亿美元，市盈率为-7.13，贝塔系数为 1.51。Cresco Labs 的 1 年最低价为$0.43，1 年最高价为$1.62。该公司的 50 日简单移动平均线为$1.21，200 日简单移动平均线为$0.89。公司的流动比率为 3.10，速动比率为 2.22，债务与股本比率为 1.33。</p>
<h2>华尔街分析师观点</h2>
<p>另外，Zacks Research 在 10 月 14 日（星期二）的一份研究报告中将 Cresco Labs 的股票评级从 “持有” 下调至 “强烈卖出”。一位研究分析师给予该股票 “强烈买入” 评级，一位给予 “持有” 评级，还有一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “持有”。</p>
<p><strong>获取我们最新的 CRLBF 股票报告</strong></p>
<h2>关于 Cresco Labs</h2>
<p>（获取免费报告）</p>
<p>Cresco Labs Inc 及其子公司在美国从事大麻产品的种植、制造和销售。它提供以 Cresco 品牌销售的花朵、大麻蒸汽笔、活树脂、一次性笔和提取物；以 High Supply 品牌销售的蒸汽罐、蒸汽笔、花朵、爆米花、摇晃、预卷、短卷和浓缩物；以 Good News 品牌销售的蒸汽和软糖；以 Wonder Wellness Co 品牌销售的蒸汽和食品；以及以 Remedi 品牌销售的酊剂、胶囊、药膏和舌下油。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票超过 Cresco Labs</li>
<li>深入了解买卖差价</li>
<li>Rivian 的图表显示可以买入，但一些分析师仍然表示不建议买入</li>
<li>投资旅游股票的好处</li>
<li>e.l.f.的抛售是买入的好时机，分析师表示</li>
<li>找到并盈利交易 52 周低点的股票</li>
<li>T-Mobile 是最被低估的巨型股票——现在是买入时机吗？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Cresco Labs 吗？</h2>
<p>在考虑 Cresco Labs 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前买入……而 Cresco Labs 并不在名单上。</p>
<p>虽然 Cresco Labs 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得买入。</p>
<p>在这里查看这五只股票</p>

CRLBF

<p>Cresco Labs (OTCMKTS:CRLBF) 报告的季度每股收益为（$0.05），低于预期 $0.02。收入为 1.65 亿美元，超过预期的 1.6374 亿美元。该公司的股本回报率为负 11.77%，净利润率为负 6.67%。分析师已将该股票评级从 “持有” 下调至 “强烈卖出”，共识评级为 “持有”。该股票开盘价为 $1.07，市值为 3.8085 亿美元，市盈率为 -7.13</p>

<p>Cresco Labs (OTCMKTS:CRLBF - Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.02), Zacks reports. The business had revenue of $165.00 million during the quarter, compared to analyst estimates of $163.74 million. Cresco Labs had a negative return on equity of 11.77% and a negative net margin of 6.67%.</p>
<div class="lb-trans"><p>Cresco Labs（OTCMKTS:CRLBF - 获取免费报告）于周五发布了季度财报。该公司报告的每股收益（EPS）为（$0.05），低于市场共识预期的（$0.03），差距为（$0.02），据 Zacks 报道。该季度的收入为 1.65 亿美元，而分析师预期为 1.6374 亿美元。Cresco Labs 的股本回报率为负 11.77%，净利润率为负 6.67%。</p>
</div><h2>Cresco Labs Price Performance</h2>
<div class="lb-trans"><h2>Cresco Labs 价格表现</h2>
</div><p>OTCMKTS:CRLBF opened at $1.07 on Friday. The stock has a market capitalization of $380.85 million, a PE ratio of -7.13 and a beta of 1.51. Cresco Labs has a 1-year low of $0.43 and a 1-year high of $1.62. The firm has a fifty day simple moving average of $1.21 and a 200 day simple moving average of $0.89. The company has a current ratio of 3.10, a quick ratio of 2.22 and a debt-to-equity ratio of 1.33.</p>
<div class="lb-trans"><p>OTCMKTS:CRLBF 周五开盘价为$1.07。该股票的市值为 3.8085 亿美元，市盈率为-7.13，贝塔系数为 1.51。Cresco Labs 的 1 年最低价为$0.43，1 年最高价为$1.62。该公司的 50 日简单移动平均线为$1.21，200 日简单移动平均线为$0.89。公司的流动比率为 3.10，速动比率为 2.22，债务与股本比率为 1.33。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Separately, Zacks Research cut shares of Cresco Labs from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report on Tuesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of &#34;Hold&#34;.</p>
<div class="lb-trans"><p>另外，Zacks Research 在 10 月 14 日（星期二）的一份研究报告中将 Cresco Labs 的股票评级从 “持有” 下调至 “强烈卖出”。一位研究分析师给予该股票 “强烈买入” 评级，一位给予 “持有” 评级，还有一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “持有”。</p>
</div><p><strong>Get Our Latest Stock Report on CRLBF</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 CRLBF 股票报告</strong></p>
</div><h2>About Cresco Labs</h2>
<div class="lb-trans"><h2>关于 Cresco Labs</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.</p>
<div class="lb-trans"><p>Cresco Labs Inc 及其子公司在美国从事大麻产品的种植、制造和销售。它提供以 Cresco 品牌销售的花朵、大麻蒸汽笔、活树脂、一次性笔和提取物；以 High Supply 品牌销售的蒸汽罐、蒸汽笔、花朵、爆米花、摇晃、预卷、短卷和浓缩物；以 Good News 品牌销售的蒸汽和软糖；以 Wonder Wellness Co 品牌销售的蒸汽和食品；以及以 Remedi 品牌销售的酊剂、胶囊、药膏和舌下油。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Cresco Labs</li>
<li>A Deeper Look at Bid-Ask Spreads</li>
<li>Rivian’s Chart Says Go, But Some Analysts Still Say No</li>
<li>Investing in Travel Stocks Benefits</li>
<li>e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts</li>
<li>Find and Profitably Trade Stocks at 52-Week Lows</li>
<li>T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Cresco Labs</li>
<li>深入了解买卖差价</li>
<li>Rivian 的图表显示可以买入，但一些分析师仍然表示不建议买入</li>
<li>投资旅游股票的好处</li>
<li>e.l.f.的抛售是买入的好时机，分析师表示</li>
<li>找到并盈利交易 52 周低点的股票</li>
<li>T-Mobile 是最被低估的巨型股票——现在是买入时机吗？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=OTCMKTS&amp;Symbol=CRLBF"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cresco Labs Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Cresco Labs 吗？</h2>
</div><p>Before you consider Cresco Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cresco Labs 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前买入……而 Cresco Labs 并不在名单上。</p>
</div><p>While Cresco Labs currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cresco Labs 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得买入。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cresco Labs (OTCMKTS:CRLBF) 公布了财报，每股收益比预期低 $0.02